Several studies observed high levels of proinflammatory cytokines in MDS patients [34], including TNF-α [35,36], IFN-γ [37], TGF-β, IL-6 [38], or IL-8 [39] with a potential independent risk factor of progression [40]. This evidence concerns the gene IL6 and myelodysplastic syndrome.